Osteochondral Grafts and Bone Transplants

Total Page:16

File Type:pdf, Size:1020Kb

Osteochondral Grafts and Bone Transplants OSTEOCHONDRAL GRAFTS AND BONE TRANSPLANTS Tom Merrill, D.P.M. E. Dalton McGlamry, D.P.M. Kieran Mahan, D.P.M. lntroduction Barth, Marchand, and Athausen each individually outlined various theories describing bone healing at the The use of bone graft materials has greatly enhanced turn of the century. This description of the invasion of the surgical procedures available for the reconstruction the f resh allogeneic bone by the host cells became the of the foot and leg. Bone grafts are now commonly us- "creeping substitution" theory that in part remains ed in many podiatric procedures including the Evans essentially unchanged today (2). In 1908 Judet first calcaneal osteotomy, facilitation of arthrodesis pro- reported the implantation of osteochondral grafts in ex- cedures, packing of bone cysts, and repair of nonunions. perimental animals(9), and by 1925 Lexer had As new bone graft materials are being introduced, new documented 34 hemi or whole knee allogeneic implants reconstructive procedures are being developed. in humans. Lexer followed up the patient results in 1923 and claimed a 50% success rate (10, 11). An in-depth study of bone graft healing physiology and the complex research currently being done is unfor- Limited availability and complications associated with tunately not within the scope of this text. We will pro- allogeneic bone harvesting stimulated research in preser- vide a ground work of useful information and highlight vation and storage of bone and cartilage. Bauer in 1910 several areas of clinical interest. Prior to a discussion con- with his canine studies and Inclan in 1942 with his human cerning the evolution of bone graft technology, we will studies outline the process of sterilization and delayed first outline some basic terminology. implantation of bone (2). Bone bank research continued with equipment technology advances almost yearly. The Grafts containing only bone are intercalary grafts and process of lreeze drying was developed during world war those containing bone and cartilage are osteochondral II and applied to tissue transplants (12). grafts (1). Bone that is harvested and used within the same individual is an autograft (noun) or an autogeneic Precise microscopic documentation with animal (adj) bone graft. Bone that is harvested from a cadaver models evaluated these new bone and cartilage preser- for use in another individual is an allograft (noun) or an vation techniques. The exact cellular stages of allogeneic (adj) bone graft (2). Autogeneic bone grafts are revascularization of allogeneic vs autogeneic bone grafts fresh and unprocessed. Allogeneic bone grafts are were compared in numerous studies (13-16). Herndon available either frozen or freeze dried. Several other and Chase in1952 discussed whole joint reimplantation bone graft processing methods and materials are being in 56 dogs with autogeneic, f resh allogeneic, and f rozen used experimentally (3-7). allogeneic osteochondral grafts. All the osseous graft sites appeared to unite within 6-8 weeks with no ap- History preciable difference in function. At 5 to 6 months however, the {resh allogeneic and frozen allogeneic The idea of removing a damaged structure from a grafts began to show increased density of the subchon- human being and rebuilding the body with a replace- d ral bone area. The allogeneic ioints eventually ment part f rom another individual or even a cadaver has deteriorated. The immune reaction of the host seemed enchanted society for centuries. Today we are still strug- to ignore the transplanted cartilage and instead invad- gling with the possibilities. ed the subchondral bone (17). The first experimental investigation of autografts was As technology advanced, the problems of immune with skull trephination defects by Merrem in 1810. OIIier reaction, subchondral bone invasion, and cartilage first suggested transplanting skin, periosteum, and bone preservation were addressed (18). ln the 1960's hundreds in 1867 even before Pasteur's "germ theory of disease" of dogs underwent metacarpophalangeal joint, femoral in 1878. Macewan studied under Joseph Lister and in 1BB1 condyle, and femoral head transplants (13,14, 19,20). documented the {irst successful aseptic fresh bone allograft (B). As early as 1948 Crahann described the reconstruction Fig. 1. Preoperative radiograph shows extensive osseous structural loss fig. 2. This intra-operative photograph shows fresh f rozen intercalary in rearfoot of this 34 year old female. allogeneic calcaneal graft being remodeled prior to insertion. in- Fig. 3. Postoperative radiograph taken showing restored structure of Fig, 4. Radiograph taken six mdnths Postoperative with removal of rearfoot with calcaneal graft intact. ternal fixation devices. Trabecular pattern appears to cross graft inter- face throughout. of the metacarpophalangeal joint in a human with an Current Bone Graft Utilization autogeneic metatarsal transplant in five patients (21). The fourth and f ifth metatarsals have since been commonly At Doctors Hospital we are currentiy using bone used for metacarpal replacement or mandibular condyle prepared by three different methods. Allogeneic f reeze recon stru ction (22-25). dried bone is the most frequently used. Autogeneic bone grafts are commonly used, and fresh frozen allogeneic The replacement of a calcaneus in a 34 year old female bone grafts are used when appropriate. with a f resh f rozen allogeneic calcaneal graft at Doctors Hospital by ED McClamry, D.P.M. has set another Allogeneic Freeze Dried Bone milestone in bone graft utilization. The patient's calcaneus had been removed during surgical debride- Allogeneic freeze dried bone has proven its usefulness ment of osteomyelitis over 15 years previously. (Fig 1). on many occasions. The desired shape and size of A whole calcaneus was procured under sterile conditions cancellous or cortical bone can be easily stored and and transported to Doctors Hospital in a frozen state (Fig remodeled to the individual patient's needs (Fig 5). At 2). The graft was remodeled and inserted with AO/ASIF Doctors Hospital we currently stock between 20 and 50 fixation and reattachment of the tendo achillis (Fig 3). The allogeneic freeze dried bone grafts of various sizes. We subsequent postoperative management is ongoing and commonly order a truncated iliac crest wedge of approx- has provided a foundation for further surgical ad- imately 3.5 cm x 1.6 cm x 12 cm for the Evans calcaneal vancements (Fig a). osteotomy procedure (Fig 6). truncated bone Fig. 5. Freezedried bone can be remodeled intra-operatively to specific Fig.6, Truncated iliac crest wedge with three sides of cortical bone demands of procedure. and filling of cancellous bone is ideal for Evans calcaneal osteotomy. The dehydration process has been used for centuries taining the sterile vacuum and the low moisture environ- for the preservation and storage of food. Modern techni- ment. The initial drying of the bone depends on the ques have provided a treeze-drying process that can vacuum. The higher the vacuum the faster the freeze- store tissue in a sterile vacuum sealed container in- drying, but the total water removed depends mainly on def initely (26, 27) (Fig 7). the length of the freeze-drying cycle. The longer the bone is exposed to the vacuum and low temperature environ- In the freeze-drying process the bone is procured ment, the more moisture is removed and the lower the under sterile conditions or secondarily sterilized with residual water level. Studies show a 14 day cycle can ethylene oxide or gamma irradiation. The sterile bone usually produce a freeze-dried bone graft of less than graft is then placed in a Iiquid nitrogen storage tank C70 5 gm% residual water. Quality control is constantly main- degrees F.) (12). The low temperatures of the liquid tained with 10% of the f inal product being sacrif iced for nitrogen crystallize the moisture in the bone (Fig 8). The biological testing prior to the release of the bone graft frozen graft is then moved onto the shelf of the freeze- material. dryer. The doors are closed and the vacuum pumps are turned on. The vacuum in the chamber is maintained at The donor selection process is the most important 100 millitorr or below throughout the 14 day cycle (Fig aspect of any tissue bank requirements and strict criteria (Jones WS: Regional 9). The ice crystals are directly vaporized in the vacuum are established CH, Rutledge Atlanta environment without passing through the intermediate Tissue Bank. Tissue Donation Criteria, 1987). liquid state, thus the term "freeze-dried". The water 24 hours vapor is drawn away from the bone and into a condenser. 1. Tissue donation must occur within At the end of the cycle the containers are sealed, main- of death. lig.T,Freeze-dried bone can be ordered in many shapes and sizes and Fig. 8, Liquid nitrogen (70 degrees F.) crystallizes water moisture of stored indefinitely until needed. bone, making water easy to remove in freeze-drier. 2. If tissue donation is delayed more than 12 as the f resh allogeneic graft should be implanted within hours after death, the body must be refrigerated. 48to72 hours. Fresh allogeneic grafts can be intercalary 3. The cause of death must be known. or osteochondral with the preservation techniques be- 4. The following factors exclude tissue donation: ing different for each. In addition to the standard organ a. Sepsis donor criteria previously outlined, the following clinical b. Uncontrolled wide spread infection tests are required for fresh allogeneic bone grafts (Jones c. Extra-cranial malignancies CH, Rutledge WS: Atlanta Regional Tissue Bank. Tissue d. Hepatitis Donation Criteria, 19B7): e. current I.V. drug abuse f. auto-immune disease 1. ABO blood type g. transmissible disease or infection 2. Rh factor h. tissue irradiation 3. Blood cultures x 2 (15 minutes apart) i. chronic steroid therapy aerobic and anaerobic j. Pre-existing bone disease 4. Cram stain of graft at retrieval 5.
Recommended publications
  • Medical Policy
    Medical Policy Joint Medical Policies are a source for BCBSM and BCN medical policy information only. These documents are not to be used to determine benefits or reimbursement. Please reference the appropriate certificate or contract for benefit information. This policy may be updated and is therefore subject to change. *Current Policy Effective Date: 5/1/21 (See policy history boxes for previous effective dates) Title: Composite Tissue Allotransplantation Description/Background Composite tissue allotransplantation refers to the transplantation of histologically different tissue that may include skin, connective tissue, blood vessels, muscle, bone, and nerve tissue. The procedure is also known as reconstructive transplantation. To date, primary applications of this type of transplantation have been of the hand and face (partial and full), although there are also reported cases of several other composite tissue allotransplantations, including that of the larynx, knee, and abdominal wall. The first successful partial face transplant was performed in France in 2005, and the first complete facial transplant was performed in Spain in 2010. In the United States, the first facial transplant was done in 2008 at the Cleveland Clinic; this was a near-total face transplant and included the midface, nose, and bone. The first hand transplant with short-term success occurred in 1998 in France. However, the patient failed to follow the immunosuppressive regimen, which led to graft failure and removal of the hand 29 months after transplantation. The
    [Show full text]
  • Rapidly Growing Epstein-Barr Virus-Associated Pulmonary Lymphoma After Heart Transplantation
    Eur Respir J., 1994, 7, 612–616 Copyright ERS Journals Ltd 1994 DOI: 10.1183/09031936.94.07030612 European Respiratory Journal Printed in UK - all rights reserved ISSN 0903 - 1936 CASE REPORT Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart transplantation M. Schwend*, M. Tiemann**, H.H. Kreipe**, M.R. Parwaresch**, E.G. Kraatz+, G. Herrmann++, R.P. Spielmann$, J. Barth* Rapidly growing Epstein-Barr virus-associated pulmonary lymphoma after heart trans- Dept of *Internal Medicine, **Hemato- plantation. M. Schwend, M. Tiemann, H.H. Kreipe, M.R. Parwaresch, E.G. Kraatz, G. pathology, +Cardiovascular Surgery, Herrmann, R.P. Spielmann, J. Barth. ERS Journals Ltd 1994. ++Cardiology, and $Radiographic Diagnostics, ABSTRACT: There is strong evidence to show an association of Epstein-Barr virus Christian-Albrechts-University of Kiel, Kiel, Germany. (EBV) infection with the development of post-transplant lymphoproliferative dis- ease. We report the rapid development of a malignant lymphoma in a heart trans- Correspondence: J. Barth plant recipient, which occurred within less than eight weeks. I. Medizinische Universitätsklinik The diagnosis of this malignant high grade B-cell lymphoma was established by Schittenhelmstr. 12 open lung biopsy, and classified as centroblastic lymphoma of polymorphic subtype. D-24105 Kiel Immunohistochemically, the lymphoma showed reactivity with the B-cell markers Germany L-26 (CD20) and Ki-B5 and with the activation marker Ber-H2 (CD30). Furthermore, an expression of the bcl-2 oncoprotein was detected. Monoclonal JH gene rearrange- Keywords: Epstein-Barr virus ment was demonstrated by polymerase chain reaction (PCR), indicating monoclonal heart transplantation pulmonary lymphoma proliferation of B-blasts.
    [Show full text]
  • 3Rd Quarter 2001 Bulletin
    In This Issue... Promoting Colorectal Cancer Screening Important Information and Documentaion on Promoting the Prevention of Colorectal Cancer ....................................................................................................... 9 Intestinal and Multi-Visceral Transplantation Coverage Guidelines and Requirements for Approval of Transplantation Facilities12 Expanded Coverage of Positron Emission Tomography Scans New HCPCS Codes and Coverage Guidelines Effective July 1, 2001 ..................... 14 Skilled Nursing Facility Consolidated Billing Clarification on HCPCS Coding Update and Part B Fee Schedule Services .......... 22 Final Medical Review Policies 29540, 33282, 67221, 70450, 76090, 76092, 82947, 86353, 93922, C1300, C1305, J0207, and J9293 ......................................................................................... 31 Outpatient Prospective Payment System Bulletin Devices Eligible for Transitional Pass-Through Payments, New Categories and Crosswalk C-codes to Be Used in Coding Devices Eligible for Transitional Pass-Through Payments ............................................................................................ 68 Features From the Medical Director 3 he Medicare A Bulletin Administrative 4 Tshould be shared with all General Information 5 health care practitioners and managerial members of the General Coverage 12 provider/supplier staff. Hospital Services 17 Publications issued after End Stage Renal Disease 19 October 1, 1997, are available at no-cost from our provider Skilled Nursing Facility
    [Show full text]
  • Exploring Vigilance Notification for Organs
    NOTIFY - E xploring V igilanc E n otification for o rgans , t issu E s and c E lls NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation e 10,00 Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 NOTIFY Exploring VigilancE notification for organs, tissuEs and cElls A Global Consultation Organised by CNT with the co-sponsorship of WHO and the participation of the EU-funded SOHO V&S Project February 7-9, 2011 Cover Bologna, piazza del Nettuno (photo © giulianax – Fotolia.com) © Testi Centro Nazionale Trapianti © 2011 EDITRICE COMPOSITORI Via Stalingrado 97/2 - 40128 Bologna Tel. 051/3540111 - Fax 051/327877 [email protected] www.editricecompositori.it ISBN 978-88-7794-758-1 Index Part A Bologna Consultation Report ............................................................................................................................................7 Part B Working Group Didactic Papers ......................................................................................................................................57 (i) The Transmission of Infections ..........................................................................................................................59 (ii) The Transmission of Malignancies ....................................................................................................................79 (iii) Adverse Outcomes Associated with Characteristics, Handling and Clinical Errors
    [Show full text]
  • Bone Grafting, Its Principle and Application: a Review
    OSTEOLOGY AND RHEUMATOLOGY Open Journal PUBLISHERS Review Bone Grafting, Its Principle and Application: A Review Haben Fesseha, MVSc, DVM1*; Yohannes Fesseha, MD2 1Department of Veterinary Surgery and Diagnostic Imaging, School of Veterinary Medicine, Wolaita Sodo University, P. O. Box 138, Wolaita Sodo, Ethiopia 2College of Health Science, School of Medicine, Mekelle University, P. O. Box1871, Mekelle, Ethiopia *Corresponding author Haben Fesseha, MVSc, DVM Assistant Professor, Department of Veterinary Surgery and Diagnostic Imaging, School of Veterinary Medicine, Wolaita Sodo University, P. O. Box: 138, Wolaita Sodo, Ethiopia;; E-mail: [email protected] Article information Received: March 3rd, 2020; Revised: March 20th, 2020; Accepted: April 11th, 2020; Published: April 22nd, 2020 Cite this article Fesseha H, Fesseha Y. Bone grafting, its principle and application: A review. Osteol Rheumatol Open J. 2020; 1(1): 43-50. doi: 10.17140/ORHOJ-1-113 ABSTRACT Bone grafting is a surgical procedure that replaces missing bone through transferring bone cells from a donor to the recipient site and the graft could be from a patient’s own body, an artificial, synthetic, or natural substitute. Bone grafts and bone graft substitutes are indicated for a variety of orthopedic abnormalities such as comminuted fractures (due to car accidents, falling from a height or gunshot injury), delayed unions, non-unions, arthrodesis, osteomyelitis and congenital diseases (rickets, abnormal bone development) and are used to provide structural support and enhance bone healing. Autogenous, allogeneic, and artificial bone grafts are common types and sources of grafts and the advancement of allografts, synthetic bone grafts, and new operative techniques may have influenced the use of bone grafts in recent years.
    [Show full text]
  • MSBCBS Prior Authorization List: Codes to Be Deleted 9/27/10
    MSBCBS Prior Authorization List: Codes to be Deleted 9/27/10 FOREHEAD FLAP WITH PRESERVATION OF VASCULAR PEDICLE (EG, AXIAL PATTERN 1 15731 FLAP) ABLATION, CRYOSURGICAL, OF FIBROADENOMA, INCLUDING ULTRASOUND 2 19105 GUIDANCE, EACH FIBROADENOMA COMPUTER-ASSISTED SURGICAL NAVIGATIONAL PROCEDURE FOR MUSCULOSKELETAL PROCEDURES, IMAGE-LESS (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY 3 20985 PROCEDURE) 4 21125 AUGMENTATION, MANDIBULAR BODY OR ANGLE; PROSTHETIC MATERIAL AUGMENTATION, MANDIBULAR BODY OR ANGLE; WITH BONE GRAFT, ONLAY OR 5 21127 INTERPOSITIONAL (INCLUDES OBTAINING AUTOGRAFT) 6 21137 REDUCTION FOREHEAD; CONTOURING ONLY REDUCTION FOREHEAD; CONTOURING AND APPLICATION OF PROSTHETIC MATERIAL 7 21138 OR BONE GRAFT (INCLUDES OBTAINING AUTOGRAFT) REDUCTION FOREHEAD; CONTOURING AND SETBACK OF ANTERIOR FRONTAL SINUS 8 21139 WALL 9 21210 GRAFT, BONE; NASAL, MAXILLARY AND MALAR AREAS (INCLUDES OBTAINING GRAFT) 10 21215 GRAFT, BONE; MANDIBLE (INCLUDES OBTAINING GRAFT) ARTHROPLASTY, TEMPOROMANDIBULAR JOINT, WITH OR WITHOUT AUTOGRAFT 11 21240 (INCLUDES OBTAINING GRAFT) 12 21740 RECONSTRUCTIVE REPAIR OF PECTUS EXCAVATUM OR CARINATUM; OPEN RECONSTRUCTION REPAIR OF PECTUS EXCAVATUM OR CARINATUM; MINIMALLY 13 21742 INVASIVE APPROACH (NUSS PROCEDURE), WITHOUT THORACOSCOPY RECONSTRUCTIVE REPAIR OF PECTUS EXCAVATUM OR CARINATUM; MINIMALLY 14 21743 INVASIVE APPROACH (NUSS PROCEDURE), WITH THORACOSCOPY EXTRACORPOREAL SHOCK WAVE, HIGH ENERGY, PERFORMED BY A PHYSICIAN, REQUIRING ANESTHESIA OTHER THAN LOCAL, INCLUDING ULTRASOUND GUIDANCE, 15 28890 INVOLVING
    [Show full text]
  • AMRITA HOSPITALS AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR)
    AMRITA HOSPITALS HOSPITALS AMRITA AMRITA AMRITA HOSPITALS HOSPITALS Kochi * Faridabad (Delhi NCR) Kochi * Faridabad (Delhi NCR) A Comprehensive A Comprehensive Overview Overview A Comprehensive Overview AMRITA INSTITUTE OF MEDICAL SCIENCES AIMS Ponekkara P.O. Kochi, Kerala, India 682 041 Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org Copyright@2018 AMRITA HOSPITALS Kochi * Faridabad (Delhi-NCR) A COMPREHENSIVE OVERVIEW A Comprehensive Overview Copyright © 2018 by Amrita Institute of Medical Sciences All rights reserved. No portion of this book, except for brief review, may be reproduced, stored in a retrieval system, or transmitted in any form or by any means —electronic, mechanical, photocopying, recording, or otherwise without permission of the publisher. Published by: Amrita Vishwa Vidyapeetham Amrita Institute of Medical Sciences AIMS Ponekkara P.O. Kochi, Kerala 682041 India Phone: (91) 484-2801234 Fax: (91) 484-2802020 email: [email protected] website: www.amritahospitals.org June 2018 2018 ISBN 1-879410-38-9 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA AMRITA HOSPITALS KOCHI * FARIDABAD (DELHI-NCR) A COMPREHENSIVE OVERVIEW 2018 Amrita Institute of Medical Sciences and Research Center Kochi, Kerala INDIA CONTENTS Mission Statement ......................................... 04 Message From The Director ......................... 05 Our Founder and Inspiration Sri Mata Amritanandamayi Devi .................. 06 Awards and Accreditations .........................
    [Show full text]
  • CIBMTR Scientific Working Committee Research Portfolio July 1, 2018
    CIBMTR Scientific July 1, Working Committee 2018 Research Portfolio Milwaukee Campus Minneapolis Campus Medical College of Wisconsin National Marrow Donor Program/ 9200 W Wisconsin Ave, Suite Be The Match – 500 N 5th St C5500 Minneapolis, MN 55401-9959 USA Milwaukee, WI 53226 USA (763) 406-5800 (414) 805-0700 cibmtr.org CIBMTR Scientific Working Committee Research Portfolio: July 1, 2018 TABLE OF CONTENTS 1.0 OVERVIEW .................................................................................................................................................................. 1 1.1 Membership ........................................................................................................................................................... 2 1.2 Leadership .............................................................................................................................................................. 2 1.3 Productivity ............................................................................................................................................................ 3 1.4 How to Get Involved ............................................................................................................................................ 3 2.0 ACUTE LEUKEMIA WORKING COMMITTEE .................................................................................................. 6 2.1 Leadership .............................................................................................................................................................
    [Show full text]
  • Clinical Considerations in Facial Transplantation
    CLINICAL CONSIDERATIONS IN FACIAL TRANSPLANTATION by Anthony Renshaw A thesis submitted in fulfilment of the requirements of University College London for the degree of Doctor of Medicine January 2011 Department of Plastic and Reconstructive Surgery, Academic Division of Surgical & Interventional Sciences, University College London 1 Declaration I, Anthony Renshaw, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. …………………………………………………………. 2 Abstract Facial transplantation has emerged as the next step on the reconstructive ladder for severe facial disfigurement. Clinical issues surrounding facial tissue donation are examined, comprising pre-transplant facial vessel delineation; pre-operative aesthetic matching; and attitudes towards donation. An anatomical study of 200 consecutive facial and transverse facial vessels was performed using colour Doppler ultrasound. Facial vessels were measured at three landmarks and their branching pattern documented. The facial artery main branch was detected at the lower mandibular border in 99.5% of cases, the accompanying facial vein in 97.5%. The transverse facial artery was present in 75.5% of cases, the vein found in 58%. When the facial artery was undetectable, there was transverse facial artery dominance. When the facial vein was absent it was replaced with a transverse facial vein. This provides valuable pre-operative information regarding vessel status. A quantitative eleven- point skin tonal matching scheme is described using digital analysis of facial imagery.
    [Show full text]
  • Consent for Bone Grafting
    Consent for Bone Grafting Grafting Procedure: __________________________________________________________________________ I understand that bone grafting and barrier membrane procedures include inherent risks such as, but not limited to the following: 1. Pain. Some discomfort is inherent in any oral surgery procedure. Grafting with materials that do not have to be harvested from your body is less painful because they do not require a donor site surgery, but pos-toperative pain is still likely. It can be largely controlled with pain medications and applying a cold compression to the surgical site. 2. Infection. No matter how carefully surgical sterility is maintained, it is possible, because of the existing non-sterile oral environment, for infections to occur post-operatively. At times these may be a serious nature. Should severe swelling occur, particularly accompanied with fever or malaise, professional attention should be received as soon as possible. 3. Bleeding, bruising, and swelling. Some moderate bleeding may last several hours. If profuse, you must contact us as soon as possible. Some swelling is normal, but if severe, you should notify us. Swelling usually starts to subside after about 48 hours. Bruises may persist for a week or so. 4. Loss of all or part of the graft. Success with bone and membrane grafting is high. Nevertheless, it is possible that the graft could fail. Despite meticulous surgery, particulate bone graft materials can migrate out of the surgery site and be lost. A membrane graft could start to dislodge. If so, the doctor should be notified. You compliance is essential to assure success. 5. Types of graft material.
    [Show full text]
  • 78581/2020/Estt-Ne Hr
    105 78581/2020/ESTT-NE_HR 1| T a r i f f - AIMS 106 78581/2020/ESTT-NE_HR INDEX 1. General Information ( Section A) 3 i. Out Patient Department ii. Ambulance Charges 2. General Information ( Section B) 5 i. Bed charges ii. In patient Consultation fees iii. Billing Of Surgery Anesthesia and OT Charges iv. Billing Of Surgery /Procedure/ others 3. LAB 9 4. Outsouce Lab 16 5. Blood Bank 64 6. Imaging & Radiodiagnosis 65 7. Non – Invasive Lab 80 8. Anesthesia 82 9. Cardiology and Cardiac Surgery 84 10. Critical Care Services 89 11. Baby Care 91 12. Common Procedure 94 13 Dental 94 14 Dermatology 101 15 E N T 105 16 Gastroenterology 110 17 Maxillo Facial Surgery 113 18 Nephrology 116 19 Neuro Diagnostic Lab 118 20 Oncology 112 21 Ophthalmology 136 22 Orthopedies 142 23 OBS & Gynaecology 149 24 Physiotherapy 154 25 Respiratory Medicine 156 26 Surgery & Major Procedures i. General Surgery 158 ii. Pediatric Surgery 165 iii. PlasticSurgery 170 iv. Neuro Surgery 182 27 Urology 185 28 Interventional Radiology 192 29 Interventional Pain Management 194 30 Paediatric Cardiac Surgery 197 31 Bed Side Service Charges200 2| T a r i f f - AIMS 107 78581/2020/ESTT-NE_HRSection – A GENERAL INFORMATION OUT PATIENT DEPARTMENT OPD Consultations: Superspeciality OPD Consultation * Rs. 700 Specialty OPD Consultation** Rs. 400 to 800 Note: OPD Timing Monday- Saturday ( 8:00AM – 7:00PM) *Super specialty Departments – Cardiac Surgery, Cardiology, Neurology, Neurosurgery, Oncology, Respiratory Medicine, Urology, Plastic Surgery, Gastroenterology, Endocrinology, Paediatric
    [Show full text]
  • Informed Consent for Bone Grafting Surgery
    INFORMED CONSENT FOR BONE GRAFTING SURGERY BONE GRAFTING The bone grafting procedure involves opening the gums in the area to expose the existing bone. This is then followed by placing bone material in such a manner so as to augment the existing bone horizontally or vertically. A protective barrier or membrane may then placed over the grafted bone for protection. The gums are then closed over and sutured (stitched) in place to completely cover the bone grafted area. A healing time of 4-6 months is then typically allowed for the bone graft to “take”, mature, and integrate with the surrounding native bone. As discussed, the bone graft material and membrane we’ll be using is derived from a donor source (animal or human) or synthetic. The materials I use have been documented to be safe and reliable. Expected Benefits The purpose of bone grafting in your case would be to increase the width of the existing bone to allow for proper implant placement. It may also help to harmonize the esthetics of the region. The amount of volume achieved is influenced by a number of factors. As such, some cases require multiple grafts to achieve the necessary volume in order to place an implant of a specific size. Principal Risks and Complications Although bone grafting of localized areas to increase the width of existing bone has been shown in clinical studies to be a predictable procedure, in some cases, patients do not respond successfully to the procedure and may require revision procedures to attain the desired result. Because each patient's condition is unique, the procedure may not be successful in preserving function or appearance for the long- term.
    [Show full text]